Alonso-Juárez Ernesto, Velázquez-Villoria Daniel
INSADOF Clinic, Salamanca, Spain.
Villoria Clinic, Vigo & Pontevedra, Spain.
Clin Ophthalmol. 2022 Sep 2;16:2969-2977. doi: 10.2147/OPTH.S373378. eCollection 2022.
Nowadays the Implantable Collamer Lens (ICL - STAAR Surgical. Monrovia. CA) is a refractive surgical technique offered not only when laser corneal correction is not possible but also when the patient requires premium quality indexes and when dry eye is a concern. The use of ICL phakic lenses in low myopic patients is an emanate factor to study and analyze in order to determine treatment predictability and stability in such patients. In this paper, we conducted a 1-year follow-up study on patients with myopia below -3.5D implanted with ICL lenses.
This was a retrospective analytical study that includes patients with phakic ICL implantation from 2 independent clinics with a minimum follow-up of 12 months. Visual acuity, refractive outcomes, vault, and intraocular pressure (IOP) were assessed at 1, 6 and 12 months.
Eighty-two eyes from 82 patients were included in this analysis. Mean spherical equivalent was -2.34 ± 0.82 (Range -5.50 to -1.00 D). Mean spherical implanted ICL power was -3.04 ± 0.78 D. In 25 eyes (30.5%) a Toric-ICL (TICL) was implanted with a mean TICL cylinder power of +1.64±0.64. Efficacy and security index remained stable for 12 months at 1.07 and 1.09, respectively. Mean vault at 12 months was 513.78 ± 262.87 μm and IOP was 15.63 ± 2.17 mmHg.
Phakic Implantable Collamer Lens implantation in very low myopia is a predictable, stable, safe, and effective technique with high efficacy and security indexes. Low diopter Toric ICL is also an excellent option for refractive surgery in cases of low diopter astigmatism.
如今,可植入式角膜接触镜(ICL - STAAR Surgical,蒙罗维亚,加利福尼亚州)作为一种屈光手术技术,不仅在无法进行激光角膜矫正时提供,而且在患者需要高质量指标以及存在干眼问题时也会被采用。对于低度近视患者使用ICL有晶状体眼人工晶状体是一个值得研究和分析的重要因素,以便确定此类患者的治疗可预测性和稳定性。在本文中,我们对植入ICL晶状体的近视度数低于-3.5D的患者进行了为期1年的随访研究。
这是一项回顾性分析研究,纳入了来自2家独立诊所的接受有晶状体眼ICL植入术的患者,最短随访时间为12个月。在1、6和12个月时评估视力、屈光结果、前房深度和眼压(IOP)。
本分析纳入了82例患者的82只眼。平均球镜等效度为-2.34±0.82(范围-5.50至-1.00 D)。平均植入ICL球镜度数为-3.04±0.78 D。25只眼(30.5%)植入了散光型ICL(TICL),平均TICL柱镜度数为+1.64±0.64。疗效和安全性指数在12个月时分别保持稳定在1.07和1.09。12个月时平均前房深度为513.78±262.87μm,眼压为15.63±2.17 mmHg。
在极低近视患者中植入有晶状体眼可植入式角膜接触镜是一种可预测、稳定、安全且有效的技术,具有高疗效和安全性指数。低屈光度散光型ICL也是低屈光度散光病例屈光手术的极佳选择。